News

An herbal supplement that’s marketed as a cure-all for chronic pain and sold in gas stations and smoke shops is getting ...
The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...
MDMA (Molly, ecstasy) is an empathogen widely used as a club drug that may become a future treatment for PTSD. Many respond ...
The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
Some imported cookware made with certain materials may leach "significant levels" of lead into food, which can cause serious ...
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
The drug, Dawnzera, is approved to prevent symptoms of a rare genetic disease called hereditary angioedema (HAE) in adults ...
A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The ...
Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.
Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic condition, hereditary angioedema.
In 2024, Hurricane Helene triggered a nationwide shortage of the country's intravenous (IV) fluids after damaging a facility in North Carolina. A similar IV fluid shortage was caused when Hurricane ...